Acta Med. 2009, 52: 23-25
https://doi.org/10.14712/18059694.2016.103
Thoracic Radiotherapy for Mediastinal Nodal Recurrence
References
1. Lung Cancer 2003; 42 Suppl 1:S57–64.
< R, Le Péchoux C, Pignon JP. Resected non-small cell lung cancer: need for adjuvant lymph node treatment? From hope to reality. https://doi.org/10.1016/S0169-5002(03)00309-X>
2. Int J Radiat Oncol Biol Phys 2005; 61:318–28.
< J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. https://doi.org/10.1016/j.ijrobp.2004.06.260>
3. Int J Radiat Oncol Biol Phys 1992; 24:25–30.
< WJ, Herbert SH, Stafford PM, et al. Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy? https://doi.org/10.1016/0360-3016(92)91016-G>
4. Am J Clin Oncol 1997; 20:46–50.
< B, Graham MV, Deedy M, Shapiro S, Kucik N. Radiation therapy for intrathoracic recurrence of non-small cell lung cancer. https://doi.org/10.1097/00000421-199702000-00010>
5. Lung Cancer 2003; 41:207–14.
< B, Mirkovic N, Scott C, et al. The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data. https://doi.org/10.1016/S0169-5002(03)00228-9>
6. Cancer 1978; 42:2478–82.
< N, Kern W. The clinical course and treatment results of patients with postresection locally recurrent lung cancer. https://doi.org/10.1002/1097-0142(197811)42:5<2478::AID-CNCR2820420551>3.0.CO;2-Q>
7. Lung Cancer 1999; 23:135–42.
< B, Shibamoto Y, Milicic B, et al. External beam radiation therapy alone for loco-regional recurrence of non-small-cell lung cancer after complete resection. https://doi.org/10.1016/S0169-5002(99)00007-0>
8. Lung Cancer 1998; 20:31–5.
< Y, Nishio M, Narimatsu N, et al. Radiotherapy for locoregional recurrent tumors after resection of non-small cell lung cancer. https://doi.org/10.1016/S0169-5002(98)00008-7>
9. Int J Radiat Oncol Biol Phys 2006; 65:1097–105.
< CR, Light KL, Marks LB. Patterns of failure after resection of non-smallcell lung cancer: implications for postoperative radiation therapy volumes. https://doi.org/10.1016/j.ijrobp.2006.02.007>
10. Int J Radiat Oncol Biol Phys 1980; 6:1503–6.
< G, Choi NC. Radiation therapy for postoperative local-regionally recurrent lung cancer. https://doi.org/10.1016/0360-3016(80)90007-3>
11. Lung Cancer 1999; 24:31–7.
< MK, Ten Haken RK, Hazuka MB, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. https://doi.org/10.1016/S0169-5002(99)00019-7>
12. Int J Radiat Oncol Biol Phys 2001; 50:681–5.
< KE, Sim SE, Mychalczak B, et al. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. https://doi.org/10.1016/S0360-3016(01)01482-1>
13. Radiother Oncol 1999; 53:247–55.
< S, van Sornsen de Koste J, Samson M, et al. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. https://doi.org/10.1016/S0167-8140(99)00143-7>
14. Mayo Clin Proc 1992; 67:1129–33.
< EG, Brindle JS, Creagan ET, et al. Locally recurrent non-small-cell lung cancer after complete surgical resection. https://doi.org/10.1016/S0025-6196(12)61141-0>
15. Int J Radiat Oncol Biol Phys 2001; 51:660–5.
< S, Rosenzweig KE, Schindelheim R, et al. Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer. https://doi.org/10.1016/S0360-3016(01)01666-2>
16. Int J Clin Oncol 2005; 10:425–8.
< T, Fukuda H, Nakagawa K, et al. Non-small cell lung cancer: radiation therapy for locoregional recurrence after complete resection. https://doi.org/10.1007/s10147-005-0526-5>
17. Radiother Oncol 2002; 62:11–9.
< L, Granone P, Valente S, et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. https://doi.org/10.1016/S0167-8140(01)00478-9>